Brief: Pharmena Makes Cession Of Rights And Obligations From Unit Menavitin

Pharmena SA

06/02/2023 07:22

Feb 6 (Reuters) - Pharmena SA  PHR.WA :
    * SAID ON FRIDAY IT HAS MADE CESSION OF RIGHTS AND
OBLIGATIONS
FROM UNIT MENAVITIN UNDER SIGNIFICANT AGREEMENTS CONCERNING
PRODUCTS TRADED ON THE GERMAN MARKET UNDER MENAVITIN TRADEMARK
FOR EUR 32,500
    * COMPANY ALSO PLANS TO LIQUIDATE SAID UNIT AND CONTINUE TO
SELL
PRODUCTS UNDER THE MENAVITIN BRAND DIRECTLY BY ITSELF
    * AS A CONSEQUENCE, COMPANY HAS DECIDED TO BOOK WRITE-DOWN
ON
UPDATED VALUE OF SHARES AND LOANS GRANTED TO MENAVITIN 
    * SAID WRITE-DOWN TO BE BOOKED AT COMPANY'S 2022 STANDALONE
FINANCIAL STATEMENT LEVEL AND WILL INCREASE FINANCIAL COSTS BY
4.94 MILLION ZLOTYS

        
 Source text for Eikon:  urn:newsml:reuters.com:*:nEMc2795ma
 Further company coverage:  PHR.WA  
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))